HeartSciences (HSCS) Total Current Liabilities (2022 - 2026)

HeartSciences has reported Total Current Liabilities for 5 years, with the latest figure at $4.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 19.53% year-over-year to $4.3 million; the trailing twelve-month figure through Jan 2026 stood at $4.3 million (up 19.53% YoY), and the FY2025 full-year result was $3.7 million, up 111.4% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $4.3 million, up from $1.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $4.3 million in Q1 2026, with the low at $1.4 million in Q3 2024.
• Historically, Total Current Liabilities has averaged $2.6 million across 5 years, with a median of $2.5 million in 2023.
• The largest YoY upside for Total Current Liabilities was 123.02% in 2025 against a maximum downside of 52.57% in 2025.
• HeartSciences' Total Current Liabilities stood at $3.1 million in 2022, then increased by 12.5% to $3.5 million in 2023, then fell by 6.47% to $3.3 million in 2024, then slumped by 52.57% to $1.6 million in 2025, then jumped by 172.53% to $4.3 million in 2026.
• The last three Total Current Liabilities figures came in at $4.3 million (Q1 2026), $1.6 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.